Psoriatic Arthritis D2P Screening

Summary

The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis. Previously developed screening questionnaires were intended for use in the setting of a doctor's office to assist providers with referral decisions. However, these screening questionnaires are infrequently used in routine practice because of limitations with time and resources. The study will aim to develop a practical screening strategy that does not require involvement from dermatologists (or other non-rheumatology providers) and can systematically reach a broad range of psoriasis patients, including patients not attending dermatology clinics. The researchers hypothesize that disseminating questionnaires directly to patients outside of a clinic setting (direct-to-patient approach) will educate patients about their PsA risk and improve early PsA diagnoses.

Eligibility

Inclusion Criteria:

* Have an International Classification of Diseases (ICD) code diagnosis of psoriasis but without a confirmed diagnosis of Psoriatic Arthritis prior to study initiation
* Be age 18 or older
* Be geographically located within a reasonable proximity to the Rheumatology study site

Exclusion Criteria:

* Have psoriasis and a confirmed diagnosis of psoriatic arthritis made or confirmed by a rheumatologist

Conditions2

Locations2 sites

Browse More Trials